knowledge -WSS

knowledge

author：explore 2025-09-03 15:25:56 - browse：19

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Boeing's 1st astronaut flight bumped into next year, more repairs needed

WSS

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Biden will tout long

Mississippi candidates for statewide offices square off in party primaries

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

At least 12 people were injured in a blast at a port in northwest Turkey

focus

knowledge

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

At least 13 dead in Texas as scorching temps continue

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Medical records are filled with copy

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Medical leaders decry Supreme Court decision on affirmative action

Lab trade group sues FDA to halt regulation of lab

hotspot

David Sabatini, ex

Childbirth

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Scientists successfully use ultrasound imaging to map brain activity

Startling documents reveal new facets of Sacklers' opioid empire

Trump Jan. 6 attorney John Lauro is ex

hotspot

focus

entertainment

Wikipedia